
News|Articles|July 17, 2025
Could targeting retinal non-perfusion be the key to achieving true disease modification in diabetic retinopathy?
Advertisement
Advertorial:
The triad of inflammation, neuropathy, and vasculopathy plays a key role in the development and progression of diabetic retinopathy (DR). Dr. Varun Chaudhary and Dr. Patrick Bussfeld, discuss how retinal non-perfusion (RNP) specifically drives disease progression and why it should be explored as a treatment target.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
FDA guidance to help accelerate cell and gene therapies
2
The Retina TL;DR with Dr. Weng: Clinical trials, career, and community with David A. Eichenbaum, MD, FASRS
3
Clinical Trials at the Summit 2026: First-time data, AI, and the next generation of retinal treatments
4



















